Aldeyra Therapeutics, Inc.
Pharmaceutical Preparations · Lexington, MA, United States
- PrincipalsTodd C BradyPresident and CEOand 2 more
- CompanyAldeyra Therapeutics, Inc.Lexington, MA, United States
- Phone line+1 (781) 761-4904General business
Aldeyra Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ALDX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 3
Chief executive
Todd C BradyPresident and CEO
Chair & board
Richard DouglasDirector (Board)
Everyone else on file (1)
Michael AlfieriPrincipal Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Todd C Brady — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Richard Douglas — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Michael Alfieri — Principal Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Amneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capability